Quantcast
Last updated on April 19, 2014 at 1:20 EDT

Latest Unilife Corporation Stories

2012-10-25 15:24:39

YORK, Pa., Oct. 25, 2012 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS; ASX: UNS) announced today that it intends to release its financial results for the fiscal 2013 first quarter ended September 30, 2012 after market trading ends on Tuesday, October 30, 2012. Management has scheduled a conference call for 4:30 p.m. U.S. EDT on Tuesday, October 30, 2012 (Wednesday, October 31, 2012 at 7:30 a.m. AEST), to review the Company's financial results, market trends,...

2012-10-16 07:27:35

YORK, Pa., Oct. 16, 2012 /PRNewswire/ -- Unilife Corporation ("Unilife" or the "Company") (NASDAQ: UNIS; ASX: UNS) today announced the development of two new breakthrough platform technologies for targeted drug delivery that can enable and enhance patient outcomes for many acute and chronic conditions where there are high rates of occurrence but limited treatment options available. These proprietary device technologies for microliter doses and drug depot deployment have broad applicability...

2012-10-12 11:23:46

YORK, Pa., Oct. 12, 2012 /PRNewswire/ -- Unilife Corporation ("Unilife" or the "Company") (NASDAQ: UNIS; ASX: UNS) today announced that it will exhibit its portfolio of injectable drug delivery systems at the PDA Universe of Prefilled Syringes and Injection Devices being held in Las Vegas, Nevada between October 15 and 17. Unilife will be represented at this pre-eminent global industry event for injectable drug delivery systems by its commercial development team and other business leaders....

2012-10-10 07:28:04

YORK, Pa., Oct. 10, 2012 /PRNewswire/ -- Unilife Corporation ("Unilife" or the "Company") (NASDAQ: UNIS; ASX: UNS) today announced the strategic expansion of its commercial development team, with the appointment of four senior executives from several leading companies in the drug delivery device market. Mr. Alan Shortall, CEO of Unilife said: "Unilife has established a broad and market-driven portfolio of injectable drug delivery systems. The Unilife commercial pipeline is growing with many...

2012-07-30 10:24:46

YORK, Pa., July 30, 2012 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS; ASX: UNS) today announced financial results for the quarter ended June 30, 2012, (the fourth quarter of Fiscal Year 2012). Unilife CEO, Alan Shortall stated, "We are pleased to have delivered on our key business milestones set out for the past twelve months, and remain on schedule to continue this consistent trend in the current fiscal year. I believe we are at a key inflection point in our...

2012-07-09 02:25:08

YORK, Pa., July 9, 2012 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS, ASX: UNS), today announced that the United States Patent and Trademark Office (USPTO) has granted the Company U.S. Patent No. 8,167,837 for the Unifill® ready-to-fill (prefilled) syringe. This key Unilife patent, which provides Unilife and its customers with a long-term competitive advantage into 2026, covers Unilife's proprietary technology for the integration of automatic and...

2012-06-28 14:21:36

YORK, Pa., June 28, 2012 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS; ASX: UNS) today announced the pricing of its underwritten offering of 6,154,000 shares of common stock at a price of $3.25 per share. All of the shares in the offering are to be sold by Unilife. The gross proceeds of the offering to the Company are expected to be $20,000,500 and net proceeds, after deducting the underwriting discount and estimated offering expenses, are expected to be...

2012-06-18 06:30:12

YORK, Pa., June 18, 2012 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS; ASX: UNS) today announced the signing of a seven-year commercial supply contract with a pharmaceutical company for the Unifill® ready-to-fill (prefilled) syringe. Target Drug and MarketThis supply contract for the Unifill syringe relates to the planned launch of a generic equivalent of an approved auto-immune therapy that is currently available in a...

2012-06-01 06:23:55

YORK, Pa., June 1, 2012 PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS, ASX: UNS), today announced that it will be presenting at the Jefferies 2012 Global Healthcare Conference in New York City. Alan Shortall, Chief Executive Officer of Unilife, is scheduled to present at 11:00 a.m. EDT on Thursday, June 7, 2012. The conference presentation will be broadcast over the Internet as a "live" listen only Webcast. To listen, please go to:...

2012-04-26 10:25:34

YORK, Pa., April 26, 2012 /PRNewswire/ -- Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS; ASX: UNS) today announced financial results for the quarter ended March 31, 2012 (the third quarter of Fiscal Year 2012). Recent Highlights: Supplying pharmaceutical companies with shipments of the Unifill ready-to-fill (prefilled) syringe. Further expansion of the Unilife AutoInfusor platform of wearable, disposable pumps for the self-administration of large-volume dose....